222 related articles for article (PubMed ID: 22950641)
1. The effects of vitamin E-coated membrane dialyzer compared to simvastatin in patients on chronic hemodialysis.
Kirmizis D; Papagianni A; Dogrammatzi F; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
Ren Fail; 2012; 34(9):1135-9. PubMed ID: 22950641
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.
Kirmizis D; Papagianni A; Belechri AM; Memmos D
Nephrol Dial Transplant; 2011 Jul; 26(7):2296-301. PubMed ID: 21127134
[TBL] [Abstract][Full Text] [Related]
3. A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.
Panichi V; Rosati A; Paoletti S; Ferrandello P; Migliori M; Beati S; Bernabini G; Daini R; Casani A; Angelini D; Parrini M; Rossi A; Petrone I; Barsotti G; Donadio C; Donati G; Grazi G; Manca Rizza G; Garosi G; Sansoni E; Braccagni B; Sidoti A; Boracelli D; Biagioli M; Moriconi L; Finato V; Mannarino A; Grimaldi C; Pansa F; Imperiali P; Mura C; Bianchi S; Bigazzi R
Blood Purif; 2011; 32(1):7-14. PubMed ID: 21242686
[TBL] [Abstract][Full Text] [Related]
4. Effects of simvastatin on markers of inflammation, oxidative stress and endothelial cell apoptosis in patients on chronic hemodialysis.
Kirmizis D; Papagianni A; Dogrammatzi F; Skoura L; Belechri AM; Alexopoulos E; Efstratiadis G; Memmos D
J Atheroscler Thromb; 2010 Dec; 17(12):1256-65. PubMed ID: 20885069
[TBL] [Abstract][Full Text] [Related]
5. Impact of inflammation on anti-oxidative effects of vitamin E-coated membrane dialyzer in patients on chronic hemodialysis.
Kirmizis D; Papagianni A; Efstratiadis G; Memmos D
Hemodial Int; 2014 Oct; 18(4):751-7. PubMed ID: 24641709
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro effects of simvastatin on inflammatory markers in pre-dialysis patients.
Panichi V; Paoletti S; Mantuano E; Manca-Rizza G; Filippi C; Santi S; Taccola D; Donadio C; Tramonti G; Innocenti M; Casto G; Consani C; Sbragia G; Franzoni F; Galetta F; Panicucci E; Barsotti G
Nephrol Dial Transplant; 2006 Feb; 21(2):337-44. PubMed ID: 16249194
[TBL] [Abstract][Full Text] [Related]
8. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress.
Takouli L; Hadjiyannakos D; Metaxaki P; Sideris V; Filiopoulos V; Anogiati A; Vlassopoulos D
Ren Fail; 2010 Jan; 32(3):287-93. PubMed ID: 20370442
[TBL] [Abstract][Full Text] [Related]
10. Vascular effects of diet and statin in hypercholesterolemic patients.
Koh KK; Son JW; Ahn JY; Jin DK; Kim HS; Choi YM; Ahn TH; Kim DS; Shin EK
Int J Cardiol; 2004 Jun; 95(2-3):185-91. PubMed ID: 15193818
[TBL] [Abstract][Full Text] [Related]
11. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
[TBL] [Abstract][Full Text] [Related]
12. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
[TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis.
Yang SK; Xiao L; Xu B; Xu XX; Liu FY; Sun L
Ren Fail; 2014 Jun; 36(5):722-31. PubMed ID: 24575826
[TBL] [Abstract][Full Text] [Related]
14. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on low-density lipoprotein cholesterol, interleukin-6, and high-sensitivity C-reactive protein in end-stage renal disease.
Soliemani A; Nikoueinejad H; Tabatabaizade M; Mianehsaz E; Tamadon M
Iran J Kidney Dis; 2011 Jan; 5(1):29-33. PubMed ID: 21189431
[TBL] [Abstract][Full Text] [Related]
15. Effect of membrane permeability on inflammation and arterial stiffness: a randomized trial.
Li PK; Cheng YL; Leung CB; Szeto CC; Chow KM; Kwan BC; Ng ES; Fok QW; Poon YL; Yu AW
Clin J Am Soc Nephrol; 2010 Apr; 5(4):652-8. PubMed ID: 20203165
[TBL] [Abstract][Full Text] [Related]
16. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients.
Hodkova M; Dusilova-Sulkova S; Kalousova M; Soukupova J; Zima T; Mikova D; Malbohan IM; Bartunkova J
Ren Fail; 2006; 28(5):395-9. PubMed ID: 16825088
[TBL] [Abstract][Full Text] [Related]
17. Effects of marine omega-3 fatty acids on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ann Nutr Metab; 2011; 58(3):197-202. PubMed ID: 21757893
[TBL] [Abstract][Full Text] [Related]
18. Regional variations of low-density lipoprotein oxidizability in hemodialysis patients may explain discrepancies in interventional therapy on oxidative profile.
Morena M; Gausson V; Mothu N; Bouchet JL; Chanas M; Grandvuillemin M; Robert A; Vela C; Canaud B; Cristol JP; Olmer M
Blood Purif; 2008; 26(3):300-10. PubMed ID: 18451643
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
20. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease.
Stinghen AE; Gonçalves SM; Martines EG; Nakao LS; Riella MC; Aita CA; Pecoits-Filho R
Nephron Clin Pract; 2009; 111(2):c117-26. PubMed ID: 19147993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]